Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Clinical and Vaccine Immunology : CVI|July 18, 2008
Measurement of the humoral immune response following an incident human papillomavirus type 16 or 18 infection in young women by a pseudovirion-based neutralizing antibody assayJane Steele, Stuart Collins, Kaisheng Wen, et al.BJOG : an International Journal of Obstetrics and Gynaecology|February 16, 2002
High incidence of cervical human papillomavirus infection in women during their first sexual relationshipStuart Collins, Saeideh Mazloomzadeh, Heather Winter, et al.Journal of Medical Imaging and Radiation Oncology|February 24, 2023
Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: An institutional experienceBeini Chen, Nick Butler, Thomas O'Rourke, et al.Lancet (London, England)|January 9, 2003
Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasiaCiaran B J Woodman, Stuart Collins, Terry P Rollason, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2020
Assessment and Transplantation of Orphan Donor Livers: A Back-to-Base Approach to Normothermic Machine PerfusionJanske Reiling, Nick Butler, Andrew Simpson, et al.Health Technology Assessment (Winchester, England)|July 20, 2016
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancerNicholas James, Sarah Pirrie, Ann Pope, et al.JAMA Oncology|January 23, 2016
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical TrialNicholas D James, Sarah J Pirrie, Ann M Pope, et al.BJU International|June 4, 2016
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)Lazaros Andronis, Ilias Goranitis, Sarah Pirrie, et al.Hepatology Communications|September 25, 2022
Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensusAshika D Maharaj, John Lubel, Eileen Lam, et al.Pageof 8